Skip to main content
Premium Trial:

Request an Annual Quote

Improved Outcomes Software s GeneLinker Gold and Platinum 4.6, GeneGo s MetaDrug 1.0 and MetaCore, CueMol, E-Cell Simulation Environment, MWG Biotech s E-Commerce Website, and Rescentris CERF and CERF-Notebook


Improved Outcomes Software has released GeneLinker Gold and Platinum 4.6. The new releases are focused primarily on importing and analyzing protein biomarker data. A protein biomarker package that previously required a separate installation is now included in the software, and the software’s proteomics import scripts have also been improved. For gene expression data analysis, the company has added new data import scripts to handle Koadarray ratio and two-color data.

GeneGo has launched MetaDrug 1.0, a platform that combines software for predicting metabolites and over 40 ADME/tox properties with visualization and analysis of toxicogenomics and metabolomics data. MetaDrug can be used as a standalone product or together with MetaCore, GeneGo’s analytical platform.

CueMol, a molecular structure visualization program that operates on Windows, is available at CueMol supports molecular coordinates (PDB format), electron density (CCP4, CNS, and BRIX format), MSMS surface data, and GRASP electrostatic potential maps. It includes the QScript scripting language for batch operations.

Version 3.1.103 of the E-Cell Simulation Environment is available at New features include an improved session monitor, a model editor with a pathway viewer, and support for differential-algebraic equations.

MWG Biotech has launched an improved e-commerce website (, which includes new bioinformatics tools for designing primers, dual-labeled probes, and siRNAs. The website’s DNA sequencing allows customers to download and view their data online, and provides Phred quality reports and Blast analysis.

Rescentris has released version 2.2.1 of its CERF (Collaborative Electronic Research Framework) knowledge management platform. CERF is based on Web Ontology Language ontologies, and can be customized for specific research workflows. CERF 2.2.1 is also integrated with the company’s new CERF-Notebook, an electronic laboratory notebook module.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.